Wed, August 30, 2023
Tue, August 29, 2023
Mon, August 28, 2023

Matthew Harrison Maintained (BGNE) at Buy with Decreased Target to $319 on, Aug 29th, 2023

Matthew Harrison of Morgan Stanley, Maintained "BeiGene, Ltd." (BGNE) at Buy with Decreased Target from $321 to $319 on, Aug 29th, 2023.

Matthew has made no other calls on BGNE in the last 4 months.



There are 4 other peers that have a rating on BGNE. Out of the 4 peers that are also analyzing BGNE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Rebecca Liang of "Bernstein" Downgraded from Buy to Hold and Decreased Target to $196 on, Friday, June 30th, 2023


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $287 on, Thursday, August 17th, 2023
  • Xiling Chen of "JP Morgan" Maintained at Buy with Increased Target to $300 on, Monday, August 7th, 2023
  • Yigal Nochomovitz of "Citigroup" Initiated at Strong Buy and Held Target at $275 on, Monday, July 17th, 2023